Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuron

• Publication date

  2008-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neuron.2008.02.003PMID 18400162PMCID PMC2390913
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

  2007cited by this paper
• Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms

  2007cited by this paper
• The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

  2007cited by this paper
• A Selective Activity-Dependent Requirement for Dynamin 1 in Synaptic Vesicle Endocytosis

  2007cited by this paper
• Acute stress increases interstitial fluid amyloid-β via corticotropin-releasing factor and neuronal activity

  2007cited by this paper
• The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments

  2006cited by this paper
• LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease

  2006cited by this paper
• Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis

  2006cited by this paper
• Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-β Peptide Catabolism

  2006cited by this paper
• Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.

  2006cited by this paper
• Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers

  2006cited by this paper
• M1 receptors play a central role in modulating AD-like pathology in transgenic mice.

  2006cited by this paper
• Proneness to psychological distress and risk of Alzheimer disease in a biracial community

  2005cited by this paper
• Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

  2005cited by this paper
• Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein.

  2005cited by this paper
• Rapid Endocytosis of the Low Density Lipoprotein Receptor-related Protein Modulates Cell Surface Distribution and Processing of the β-Amyloid Precursor Protein*

  2005cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005cited by this paper
• Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein

  2005cited by this paper
• NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production

  2005cited by this paper
• NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.

  2005cited by this paper
• The Low Density Lipoprotein Receptor-related Protein 1B Retains β-Amyloid Precursor Protein at the Cell Surface and Reduces Amyloid-β Peptide Production*

  2004cited by this paper
• LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

  2004cited by this paper
• Extracellular amyloid formation and associated pathology in neural grafts

  2003cited by this paper
• Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus.

  2003cited by this paper
• APP processing and synaptic function.

  2003cited by this paper
• In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life

  2003cited by this paper
• Proneness to psychological distress is associated with risk of Alzheimer’s disease

  2003cited by this paper
• Disruption of Corticocortical Connections Ameliorates Amyloid Burden in Terminal Fields in a Transgenic Model of Aβ Amyloidosis

  2002cited by this paper
• Evidence That Synaptically Released β-Amyloid Accumulates as Extracellular Deposits in the Hippocampus of Transgenic Mice

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• PIP Kinase Iγ Is the Major PI(4,5)P2 Synthesizing Enzyme at the Synapse

  2001cited by this paper
• PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse.

  2001cited by this paper
• The selective muscarinic M1 agonist AF102B decreases levels of total Aβ in cerebrospinal fluid of patients with Alzheimer's disease

  2000cited by this paper
• Intraneuronal Aβ42 Accumulation in Human Brain

  2000cited by this paper
• Intraneuronal Abeta42 accumulation in human brain.

  2000cited by this paper
• Endogenous presenilin-1 targets to endocytic rather than biosynthetic compartments.

  2000cited by this paper
• Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE.

  1999cited by this paper
• Calcium triggers calcineurin-dependent synaptic vesicle recycling in mammalian nerve terminals.

  1998cited by this paper
• Increased apolipoprotein E ϵ4 in epilepsy with senile plaques

  1997cited by this paper
• Trafficking of cell-surface beta-amyloid precursor protein: evidence that a sorting intermediate participates in synaptic vesicle recycling.

  1997cited by this paper
• Alzheimer Amyloid Protein Precursor Is Localized in Nerve Terminal Preparations to Rab5-containing Vesicular Organelles Distinct from Those Implicated in the Synaptic Vesicle Pathway*

  1996cited by this paper
• Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

  1996cited by this paper
• Trafficking of cell-surface amyloid beta-protein precursor. I. Secretion, endocytosis and recycling as detected by labeled monoclonal antibody.

  1996cited by this paper
• Metabolism of the Swedish Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells

  1996cited by this paper
• Senile plaques in temporal lobe epilepsy

  1994cited by this paper
• Evidence that production and release of amyloid beta-protein involves the endocytic pathway.

  1994cited by this paper
• Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells.

  1993cited by this paper
• Identification of the Alzheimer beta/A4 amyloid precursor protein in clathrin-coated vesicles purified from PC12 cells.

  1993cited by this paper
• Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation

  1993cited by this paper
• Clathrin-coated vesicles in nervous tissue are involved primarily in synaptic vesicle recycling

  1992cited by this paper
• Evidence for two physiologically distinct perforant pathways to the fascia dentata.

  1980cited by this paper
• EVIDENCE FOR RECYCLING OF SYNAPTIC VESICLE MEMBRANE DURING TRANSMITTER RELEASE AT THE FROG NEUROMUSCULAR JUNCTION

  1973cited by this paper

• Exploring Linalool-Based Phytotherapy for Excitatory/Inhibitory Imbalance in Alzheimer's Disease: A Review of Lavender and Cannabis Therapeutic Effects on Sleep, Seizures, and Cognition.

  2026cites this paper
• Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models.

  2026cites this paper
• Molecular mechanisms of aging in the pathogenesis of Alzheimer’s disease

  2026cites this paper
• The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks

  2025influential citation
• Advancing Care in Alzheimer’s Disease: Current Treatments and Their Impact on Quality of Life

  2025cites this paper
• The Role of Neprilysin and Insulin-Degrading Enzyme in the Etiology of Sporadic Alzheimer's Disease

  2025cites this paper
• Longitudinal excitation-inhibition balance altered by sex and APOE-ε4

  2025cites this paper
• Adolescent Alcohol and the Spectrum of Cognitive Dysfunction in Aging.

  2025cites this paper
• Development of potent humanized TNFα inhibitory nanobodies for therapeutic applications in TNFα-mediated diseases

  2025cites this paper
• Isotope Encoded Spatial Biology Identifies Amyloid Plaque-Age-Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity

  2025cites this paper
• Super-resolution microscopy as drug discovery tool.

  2025cites this paper
• Elucidating Molecular Mechanisms Governing TNF-Alpha-Mediated Regulation of Amyloid Beta 42 Uptake in Blood-Brain Barrier Endothelial Cells

  2025cites this paper
• The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemia

  2025cites this paper
• Isotope-encoded spatial biology identifies plaque-age-dependent maturation and synaptic loss in an Alzheimer’s disease mouse model

  2025cites this paper
• Amyloid-β deposition predicts oscillatory slowing of magnetoencephalography signals and a reduction of functional connectivity over time in cognitively unimpaired adults

  2025cites this paper
• Elucidating molecular mechanisms governing tumor necrosis factor-alpha-mediated regulation of amyloid beta 42 uptake in blood-brain barrier endothelial cells.

  2025cites this paper
• Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

  2025cites this paper
• Beyond Clathrin: Decoding the Mechanism of Ultrafast Endocytosis.

  2025cites this paper
• Imaging lipid rafts reveals the principle of ApoE4-induced Aβ upregulation in human neurons

  2025cites this paper
• Integrative bioinformatics analysis of APOE variants in Alzheimer's disease and clinical therapeutics.

  2025cites this paper
• Enhanced differentiation of neural progenitor cells in Alzheimer’s disease into vulnerable immature neurons

  2025cites this paper
• Amyloid-β as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease

  2025cites this paper
• Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?

  2025cites this paper
• NCAM2 promotes targeting of APP from the cell surface to BACE1-containing recycling endosomes.

  2025cites this paper
• γ-Secretase modulation inhibits amyloid plaque formation and growth and stimulates plaque regression in amyloid precursor protein/presenilin-1 mice.

  2025cites this paper
• Amyloid beta is released by lysosomal exocytosis from hiPSC-derived neurons

  2025cites this paper
• Pathogenesis of comorbid epilepsy in Alzheimer’s disease and use of perampanel, an AMPA receptor inhibitor

  2025cites this paper
• Prospective memory performance and its resting-state functional connectivity correlates in individuals with memory complaints.

  2025cites this paper
• Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method

  2024cites this paper
• Amygdala neuronal dyshomeostasis via 5‐HT receptors mediates mood and cognitive defects in Alzheimer's disease

  2024cites this paper
• Small GTPases control macropinocytosis of amyloid precursor protein and cleavage to amyloid-β

  2024cites this paper
• Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

  2024cites this paper
• Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF ) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology.

  2024cites this paper
• Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer’s disease

  2024cites this paper
• Clathrin mediated endocytosis in Alzheimer's disease: cell type specific involvement in amyloid beta pathology.

  2024cites this paper
• Patterns of Early Neocortical Amyloid-β Accumulation: A PET Population-Based Study

  2024cites this paper
• A clathrin mediated endocytosis scaffolding protein, Intersectin 1, changes in an isoform, brain region, and sex specific manner in Alzheimer’s disease

  2024cites this paper
• Sodium channel inhibitors alter the progress of tangle development in a mouse model of dementia

  2024cites this paper
• Stabilization of mitochondria‐associated endoplasmic reticulum membranes regulates Aβ generation in a three‐dimensional neural model of Alzheimer's disease

  2024cites this paper
• GNG5 is a novel regulator of Aβ42 production in Alzheimer’s disease

  2024cites this paper
• An Overview of the Genes and Biomarkers in Alzheimer's Disease.

  2024cites this paper
• Isotope Encoded chemical Imaging Identifies Amyloid Plaque Age Dependent Structural Maturation, Synaptic Loss, and Increased Toxicity

  2024cites this paper
• Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models

  2024cites this paper
• Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies

  2024cites this paper
• Anti‐epileptic drug use and subsequent degenerative dementia occurrence

  2024cites this paper
• Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations

  2024cites this paper
• Transient sleep apnea results in long-lasting increase in β-amyloid generation and tau hyperphosphorylation.

  2024cites this paper
• Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders

  2024cites this paper
• Altered brain connectivity in mild cognitive impairment is linked to elevated tau and phosphorylated tau, but not to GAP-43 and Amyloid-β measurements: a resting-state fMRI study

  2024cites this paper
• Choline supplementation in early life improves and low levels of choline can impair outcomes in a mouse model of Alzheimer’s disease.

  2023cites this paper
• Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond

  2023cites this paper
• Patterns of early neocortical amyloid beta accumulation: a positron emission tomography population-based study

  2023cites this paper
• The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model

  2023cites this paper
• Re-Arranging the Puzzle between the Amyloid-Beta and Tau Pathology: An APP-Centric Approach

  2023cites this paper
• Pathological Correlates of Cognitive Decline in Parkinson’s Disease: From Molecules to Neural Networks

  2023cites this paper
• Lysosomal dysfunction induced cytosolic vacuolation and increased intracellular amyloid-beta 42 (Aβ42) in human brain endothelial cells (HBEC-5i).

  2023cites this paper
• Role of sleep in neurodegeneration: the consensus report of the 5th Think Tank World Sleep Forum

  2023cites this paper
• Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation.

  2023cites this paper
• Brain Waste Removal System and Sleep: Photobiomodulation as an Innovative Strategy for Night Therapy of Brain Diseases

  2023cites this paper
• Pathway-specific polygenic risk scores correlate with clinical status and Alzheimer’s-related biomarkers

  2023cites this paper
• Resting-state global brain activity affects early β-amyloid accumulation in default mode network

  2023cites this paper
• Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EVISF) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology

  2023cites this paper
• A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology

  2023cites this paper
• The Multifaceted Role of WNT Signaling in Alzheimer’s Disease Onset and Age-Related Progression

  2023cites this paper
• Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer’s disease

  2023cites this paper
• Beyond amyloid: altered gene function in neurodegenerative diseases

  2023cites this paper
• BIN1 in the Pursuit of Ousting the Alzheimer’s Reign: Impact on Amyloid and Tau Neuropathology

  2023cites this paper
• Cogs in the autophagic machine—equipped to combat dementia-prone neurodegenerative diseases

  2023influential citation
• Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases

  2023cites this paper
• Pathway-Specific Polygenic Risk Scores Correlate with Clinical Status and Alzheimer’s Disease-Related Biomarkers

  2023cites this paper
• APP-BACE1 Interaction and Intracellular Localization Regulate Aβ Production in iPSC-Derived Cortical Neurons

  2023cites this paper
• Plk2 promotes synaptic destabilization through disruption of N‐cadherin adhesion complexes during homeostatic adaptation to hyperexcitation

  2023cites this paper
• Acute inhibition of AMPA receptors by perampanel reduces amyloid β‐protein levels by suppressing β‐cleavage of APP in Alzheimer's disease models

  2023cites this paper
• PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer’s Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population

  2023cites this paper
• Neural Circuit Mechanisms Underlying the Exacerbation of Alzheimer’s Disease by Chronic Stress

  2023cites this paper
• KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer’s disease–related pathology

  2023cites this paper
• Orexin 2 receptor antagonism sex‐dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice

  2023cites this paper
• Hyperactivity of medial prefrontal cortex pyramidal neurons occurs in a mouse model of early-stage Alzheimer’s disease without β-amyloid accumulation

  2023cites this paper
• Maternal separation differentially modulates early pathology by sex in 5xFAD Alzheimer’s disease-transgenic mice

  2023cites this paper
• Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases

  2023cites this paper
• Microglia‐synapse engulfment via PtdSer‐TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models

  2023cites this paper
• Early Life Stress Enhances Cognitive Decline and Alters Synapse Function and Interneuron Numbers in Young Male APP/PS1 Mice

  2023cites this paper
• Phototherapy of Alzheimer’s Disease: Photostimulation of Brain Lymphatics during Sleep: A Systematic Review

  2023cites this paper
• Evidence for a clathrin-independent endocytic pathway for APP internalization in the neuronal somatodendritic compartment

  2023cites this paper
• Alzheimer's Disease: Narrative Review of Clinical Symptoms, Molecular Alterations, and Effective Physical and Biophysical Methods in its Improvement

  2022cites this paper
• Synaptic degeneration in Alzheimer disease

  2022cites this paper
• Neurons derived from individual early Alzheimer’s disease patients reflect their clinical vulnerability

  2022cites this paper
• Nitric oxide/cGMP/CREB pathway and amyloid-beta crosstalk: From physiology to Alzheimer's disease.

  2022cites this paper
• Based on molecular structures: Amyloid-β generation, clearance, toxicity and therapeutic strategies

  2022cites this paper
• Tight control of the APP-Mint1 interaction in regulating amyloid production

  2022cites this paper
• Chronic optogenetic activation augments Aβ pathology in a mouse model of Alzheimer disease

  2022cites this paper
• Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease

  2022cites this paper
• The mevalonate suppressor δ-tocotrienol increases AMPA receptor-mediated neurotransmission.

  2022cites this paper
• Native Planar Asymmetric Suspended Membrane for Single-Molecule Investigations: Plasma Membrane on a Chip.

  2022cites this paper
• Early β-amyloid accumulation and hypoconnectivity in the default mode network are related to its disengagement from global brain activity

  2022cites this paper
• Focal-type, but not Diffuse-type, Amyloid Beta Plaques are Correlated with Alzheimer’s Neuropathology, Cognitive Dysfunction, and Neuroinflammation in the Human Hippocampus

  2022cites this paper
• Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology

  2022cites this paper
• Enhanced cleavage of APP by co-expressed Bace1 alters the distribution of APP and its fragments in neuronal and non-neuronal cells

  2022cites this paper
• Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities

  2022cites this paper
• Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics

  2022cites this paper